Subclinical atherosclerosis: assessing the risks
Atherosclerosis: risks, mechanisms and therapies
Atherosclerosis: risks, mechanisms, therapies
Atherosclerosis: risks, mechanisms, therapies
Comprehensive and in-depth in its coverage, Atherosclerosis: Cellular, Molecular & Biochemical Mechanism and Novel Therapy reviews the recent progress in atherosclerosis research and offers cutting edge perspectives from experts in the field. Written by an international team of …
Comprehensive and in-depth in its coverage, Atherosclerosis: Cellular, Molecular & Biochemical Mechanism and Novel Therapy reviews the recent progress in atherosclerosis research and offers cutting edge perspectives from experts in the field. Written by an international team of …
Atherosclerosis: risks, mechanisms, and therapies
Comprehensive and in-depth in its coverage, Atherosclerosis: Risks, Mechanisms, and Therpies reviews the recent progress in atherosclerosis research and offers cutting edge perspectives from experts in the field. Written by an international team of authros including leading phys…
Atherosclerosis: risks, mechanisms and therapies
Comprehensive and in-depth in its coverage, Atherosclerosis: Cellular, Molecular & Biochemical Mechanism and Novel Therapy reviews the recent progress in atherosclerosis research and offers cutting edge perspectives from experts in the field. Written by an international team of …
Atherosclerosis: risks, mechanisms, therapies
Comprehensive and in-depth in its coverage, Atherosclerosis: Cellular, Molecular & Biochemical Mechanism and Novel Therapy reviews the recent progress in atherosclerosis research and offers cutting edge perspectives from experts in the field. Written by an international team of …
Given the continuing development of new statins and their increasing, beneficial use in clinical practice and given the importance of clinical research into the atherosclerotic plaque and its role in cardiovascular and endovascular diseases, given the immense advances in animal …